His lab is engaged on refining the alanine-scanning assay to a couple crucial residues that will accurately distinguish amongst fibrils from neurodegenerative tauopathies. He envisions working with this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.Quite a few colleagues have built the co